Jeremy Green's Net Worth

$0

Estimate Recalculated Jun 18, 2025 08:33PM EST

Who is Jeremy Green

Jeremy Green does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, XERIS PHARMACEUTICALS INC, RayzeBio, Inc., Allakos Inc., Science 37 Holdings, Inc., PLIANT THERAPEUTICS, INC., Stoke Therapeutics, Inc., Absci Corp, Adagio Therapeutics, Inc., Gritstone Oncology, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Allovir, Inc., IGM Biosciences, Inc., Verve Therapeutics, Inc., Nurix Therapeutics, Inc., Akero Therapeutics, Inc., Replimune Group, Inc., AMICUS THERAPEUTICS INC, FATE THERAPEUTICS INC, Kymera Therapeutics, Inc., Beam Therapeutics Inc., Augmedix, Inc., Neoleukin Therapeutics, Inc., Syros Pharmaceuticals, Inc., Atreca, Inc., VAPOTHERM INC, Shattuck Labs, Inc., TCR2 THERAPEUTICS INC., HOOKIPA Pharma Inc., Cabaletta Bio, Inc., Annexon, Inc., MedAvail Holdings, Inc., Aprea Therapeutics, Inc., ARRAY BIOPHARMA INC, Zymeworks Inc., and ADC Therapeutics SA.

SEC CIK

Jeremy Green's CIK is 0001650527

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALDER BIOPHARMACEUTICALS INC

Investor
Updated Oct 24, 2019
Form 4
-98.96%
-9.09M
Oct 24, 2019
95.24K
Options
Oct 22
Form 4
2.50%
19.02K
$137.85
$2.62M
Jul 01, 2019
779.78K
Grant
Jun 30
Form 4
22.50K
May 24, 2019
22.50K
Grant
May 23
Form 4
26.73%
1.74M
$11.50
$20.00M
Mar 06, 2019
8.24M
Grant
Mar 04
Form 4
2.50%
18.56K
$137.86
$2.56M
Jan 03, 2019
760.75K
Acquisition
Dec 31
Form 4
2.33%
16.93K
$137.85
$2.33M
Jul 18, 2018
742.20K
Acquisition
Jun 30
Form 4
15.00K
May 25, 2018
15.00K
Grant
May 23
Form 4
30.00K
Apr 26, 2018
30.00K
Grant
Apr 25
Form 3
Apr 26, 2018
6.51M
Showing 9 results

XERIS PHARMACEUTICALS INC

Investor
Updated Feb 21, 2019
Form 4
24.37%
588.00K
$10.00
$5.88M
Feb 21, 2019
3.00M
Purchase
Feb 19
Form 4
-22.42%
-697.15K
$15.00
Jun 27, 2018
2.41M
Buy-Options
Jun 25
Form 3
Jun 20, 2018
Showing 3 results

RayzeBio, Inc.

Investor
Updated Sep 21, 2023
Form 4
3.48%
62.43K
Sep 21, 2023
1.86M
Options
Sep 19
Form 3
Sep 14, 2023
Showing 2 results

Allakos Inc.

Investor
Updated Jul 24, 2018
Form 4
-20.00%
-252.28K
Jul 24, 2018
1.01M
Options
Jul 23
Form 3
Jul 18, 2018
Showing 2 results

Science 37 Holdings, Inc.

Investor
Updated Mar 13, 2024
Form 4
-100.00%
-1.12M
$5.75
-$5.85M
Mar 13, 2024
Disposition
Mar 12
Form 4
2.49%
494.85K
$0.25
$125.00K
May 15, 2023
20.34M
Grant
May 11
Form 4
$3.38
Jun 15, 2022
39.70M
Acq/Dis
Jun 13
Form 4
0.21%
40.98K
$3.05
$125.00K
May 25, 2022
19.85M
Grant
May 23
Form 4/A
296.16%
14.81M
Oct 18, 2021
19.81M
Grant
Oct 06
Form 4
41.36K
Oct 12, 2021
41.36K
Grant
Oct 07
Form 4
295.02%
14.75M
Oct 08, 2021
21.67M
Grant
Oct 06
Form 3
Oct 08, 2021
5.00M
Showing 8 results

PLIANT THERAPEUTICS, INC.

Investor
Updated Jun 09, 2020
Form 4
-86.01%
-11.75M
Jun 09, 2020
1.91M
Options
Jun 05
Form 3
Jun 02, 2020
Showing 2 results

Stoke Therapeutics, Inc.

Investor
Updated Jun 24, 2019
Form 4
Jun 24, 2019
671.81K
Options
Jun 21
Form 3
Jun 18, 2019
Showing 2 results

Absci Corp

Investor
Updated Jun 14, 2024
Form 4
0.55%
45.09K
Jun 14, 2024
8.30M
Grant
Jun 12
Form 4
2.77%
222.22K
$4.50
$1.00M
Mar 05, 2024
8.25M
Purchase
Mar 01
Form 4
53.10K
Jun 16, 2023
53.10K
Grant
Jun 14
Form 4
28.70K
Jun 10, 2022
28.70K
Grant
Jun 08
Form 4
30.46%
1.88M
$16.00
Jul 28, 2021
8.03M
Purchase
Jul 26
Form 3
Jul 21, 2021
Showing 6 results

Adagio Therapeutics, Inc.

Investor
Updated Aug 12, 2021
Form 4
76.52%
1.47M
$17.00
Aug 12, 2021
3.39M
Purchase
Aug 10
Form 3
Aug 05, 2021
Showing 2 results

Gritstone Oncology, Inc.

Investor
Updated Oct 03, 2018
Form 4
Oct 03, 2018
1.39M
Options
Oct 02
Form 3
Sep 27, 2018
Showing 2 results

Entrada Therapeutics, Inc.

Investor
Updated Nov 04, 2021
Form 4
104.78%
1.00M
$20.00
Nov 04, 2021
1.95M
Purchase
Nov 02
Form 3
Oct 28, 2021
Showing 2 results

Repare Therapeutics Inc.

Investor
Updated Jun 25, 2020
Form 4
Jun 25, 2020
1.59M
Options
Jun 23
Form 3
Jun 19, 2020
Showing 2 results

Allovir, Inc.

Investor
Updated Aug 05, 2020
Form 4
-32.90%
-403.62K
Aug 05, 2020
823.37K
Options
Aug 03
Form 3
Jul 30, 2020
Showing 2 results

IGM Biosciences, Inc.

Investor
Updated Jul 02, 2024
Form 4
0.06%
1.73K
Jul 02, 2024
3.08M
Grant
Jun 28
Form 4
-0.35%
-10.73K
Apr 01, 2024
3.08M
Disposition
Mar 28 - Mar 29
Form 4
29.40K
Mar 14, 2024
29.40K
Grant
Mar 12
Form 4
Mar 01, 2024
10.29M
Options
Feb 28
Form 4
0.02%
492.00
Jan 03, 2024
2.98M
Grant
Dec 29
Form 4
0.02%
492.00
Oct 03, 2023
2.98M
Grant
Sep 29
Form 4
0.02%
492.00
$9.42
Jul 03, 2023
5.95M
Purchase
Jun 29 - Jun 30
Form 4
62.50%
2.81M
$8.00
$22.50M
Jun 28, 2023
7.31M
Grant
Jun 26
Form 4
15.50K
Apr 06, 2023
15.50K
Grant
Apr 04
Form 4
0.01%
492.00
Apr 04, 2023
3.34M
Grant
Mar 31
Form 4
0.01%
230.00
Jan 04, 2023
3.34M
Grant
Dec 30
Form 4
$22.49
Oct 05, 2022
17.01M
Acq/Dis
Oct 03
Form 4
0.01%
230.00
Oct 04, 2022
3.34M
Grant
Sep 30
Form 4
0.01%
230.00
Jul 05, 2022
3.34M
Grant
Jun 30
Form 4
49.91%
2.61M
$23.00
$60.00M
Apr 04, 2022
7.84M
Purchase
Mar 31 - Apr 01
Form 4
29.50K
Mar 15, 2022
29.50K
Grant
Mar 12
Form 4
0.00%
130.00
Jan 04, 2022
3.34M
Grant
Dec 31
Form 4
0.00%
130.00
Oct 04, 2021
3.43M
Grant
Sep 30
Form 4
0.00%
130.00
Jul 02, 2021
3.43M
Grant
Jun 30
Form 4
0.00%
130.00
Apr 02, 2021
3.43M
Grant
Mar 31
Form 4
6.42K
Feb 23, 2021
6.42K
Grant
Feb 19
Form 4
0.01%
178.00
Jan 05, 2021
3.43M
Grant
Dec 31
Form 4
667.67K
$89.99
$60.08M
Dec 15, 2020
667.67K
Purchase
Dec 11
Form 4
0.01%
178.00
Oct 05, 2020
3.43M
Grant
Oct 01
Form 4
4.41%
144.81K
$50.52
$7.32M
Sep 09, 2020
3.43M
Purchase
Sep 04 - Sep 09
Form 4
4.35%
136.65K
$47.21
$6.45M
Sep 03, 2020
3.28M
Purchase
Sep 01 - Sep 03
Form 4
0.01%
178.00
Jul 06, 2020
3.14M
Grant
Jul 01
Form 4
0.32%
10.18K
Apr 03, 2020
3.15M
Grant
Feb 05 - Apr 01
Form 4
166.21%
3.14M
$16.00
$50.30M
Sep 23, 2019
5.04M
Options
Sep 20
Form 4
12.10K
Sep 19, 2019
12.10K
Grant
Sep 17
Form 3
Sep 17, 2019
Showing 31 results

Verve Therapeutics, Inc.

Investor
Updated Jun 23, 2021
Form 4
-76.41%
-6.27M
$19.00
Jun 23, 2021
1.94M
Buy-Options
Jun 21
Form 3
Jun 16, 2021
Showing 2 results

Nurix Therapeutics, Inc.

Investor
Updated Jul 30, 2020
Form 4
Jul 30, 2020
1.18M
Options
Jul 28
Form 3
Jul 23, 2020
Showing 2 results

Akero Therapeutics, Inc.

Investor
Updated Jun 24, 2019
Form 4
-67.47%
-1.54M
Jun 24, 2019
743.80K
Options
Jun 24
Form 3
Jun 19, 2019
Showing 2 results

Replimune Group, Inc.

Investor
Updated Jul 25, 2018
Form 4
894.69%
701.27K
Jul 25, 2018
779.66K
Options
Jul 24
Form 3
Jul 19, 2018
Showing 2 results

AMICUS THERAPEUTICS INC

Investor
Updated Jun 13, 2016
Form 4
0.51%
66.30K
$7.20
$477.36K
Jun 13, 2016
12.96M
Purchase
Jun 03
Form 3
Jun 13, 2016
12.89M
Showing 2 results

FATE THERAPEUTICS INC

Managing Member
Updated Jun 11, 2024
Form 4
40.00K
Jun 11, 2024
40.00K
Grant
Jun 07
Form 4
1,413.22%
3.64M
$5.50
$20.00M
Mar 25, 2024
3.89M
Grant
Mar 21
Form 4
0.17%
44.63K
$3.72
$166.02K
Dec 28, 2023
26.32M
Purchase
Dec 26
Form 4
40.00K
Jun 08, 2023
40.00K
Grant
Jun 06
Form 4
2.15%
276.64K
$6.17
$1.71M
Apr 21, 2023
13.14M
Purchase
Apr 20 - Apr 21
Form 4
-0.29%
-142.88K
$9.74
-$1.61M
Apr 17, 2023
48.44M
Sale
Apr 13 - Apr 14
Form 4
0.16%
20.54K
Jun 13, 2022
12.98M
Grant
Jun 09
Form 4
0.05%
7.01K
Jun 04, 2021
12.96M
Grant
Jun 02
Form 4
4.63%
584.79K
$85.50
$50.00M
Jan 12, 2021
13.21M
Purchase
Jan 08
Form 4
12.60%
1.41M
$28.31
$40.00M
Jun 17, 2020
12.63M
Purchase
Jun 11
Form 4
16.00K
May 05, 2020
16.00K
Grant
May 01
Form 4
8.27%
857.14K
$17.50
$15.00M
Sep 17, 2019
11.22M
Purchase
Sep 16
Form 4
-0.89%
-25.00K
Aug 02, 2019
2.79M
Disposition
Jul 31
Form 4
16.00K
May 06, 2019
16.00K
Grant
May 03
Form 4
55.64%
3.70M
$13.50
$50.00M
Sep 27, 2018
10.36M
Purchase
Sep 25
Form 4
24.00K
Aug 02, 2018
24.00K
Grant
Jul 31
Form 3
Aug 02, 2018
6.66M
Form 3
Dec 19, 2017
6.66M
Showing 18 results

Kymera Therapeutics, Inc.

Investor
Updated Aug 25, 2020
Form 4
-37.30%
-970.08K
Aug 25, 2020
1.63M
Options
Aug 25
Form 3
Aug 20, 2020
Showing 2 results

Beam Therapeutics Inc.

Investor
Updated Feb 11, 2020
Form 4
-77.70%
-4.05M
Feb 11, 2020
1.16M
Options
Feb 10
Form 3
Feb 05, 2020
Showing 2 results

Augmedix, Inc.

Investor
Updated Jun 18, 2024
Form 4
0.08%
12.88K
Jun 18, 2024
16.42M
Grant
Jun 14
Form 4
0.02%
3.13K
Mar 19, 2024
16.41M
Grant
Mar 15
Form 4
0.01%
1.77K
Dec 19, 2023
16.41M
Grant
Dec 15
Form 4
15.14%
3.69M
$4.00
$6.00M
Nov 22, 2023
28.04M
Purchase
Nov 20
Form 4
0.01%
2.09K
$4.78
$10.00K
Sep 05, 2023
15.65M
Grant
Aug 31
Form 4
0.14%
21.60K
Jul 17, 2023
15.65M
Grant
Jul 13
Form 4
-13.79%
-5.00M
$3.00
-$15.00M
May 04, 2023
31.26M
Disposition
May 02
Form 4/A
35.38%
1.63M
$4.00
$6.50M
Apr 21, 2023
6.22M
Purchase
Oct 28
Form 4
30.42%
4.38M
$1.60
$7.00M
Apr 21, 2023
18.76M
Grant
Apr 19
Form 4
12.74%
1.63M
$4.00
$6.50M
Nov 01, 2021
14.38M
Purchase
Oct 28
Form 4
64.47%
5.00M
$3.00
$15.00M
Oct 07, 2020
12.76M
Purchase
Oct 05
Form 3
Oct 07, 2020
7.76M
Showing 12 results

Neoleukin Therapeutics, Inc.

Investor
Updated Apr 06, 2020
Form 4
4.52%
174.63K
$10.77
$1.79M
Apr 06, 2020
4.04M
Purchase
Mar 27 - Apr 02
Form 3
Apr 06, 2020
3.87M
Showing 2 results

Syros Pharmaceuticals, Inc.

Investor
Updated Jul 07, 2016
Form 4
-39.88%
-849.27K
$12.50
$5.41M
Jul 07, 2016
1.28M
Buy-Options
Jul 06
Form 3
Jun 29, 2016
Showing 2 results

Atreca, Inc.

Investor
Updated Jun 24, 2019
Form 4
Jun 24, 2019
715.31K
Options
Jun 24
Form 3
Jun 19, 2019
Showing 2 results

VAPOTHERM INC

Investor
Updated Nov 16, 2018
Form 4
-92.73%
-12.23M
Nov 16, 2018
959.54K
Options
Nov 16
Form 3
Nov 13, 2018
Showing 2 results

Shattuck Labs, Inc.

Investor
Updated Jun 21, 2024
Form 4
27.70K
Jun 21, 2024
27.70K
Grant
Jun 21
Form 4
-0.08%
-4.42K
Apr 01, 2024
5.62M
Disposition
Mar 28
Form 4
3.10M
Dec 26, 2023
3.10M
Grant
Dec 21
Form 4
40.26K
May 31, 2023
40.26K
Grant
May 26
Form 4
40.26K
Jun 10, 2022
40.26K
Grant
Jun 08
Form 4
3.43K
Jun 22, 2021
3.43K
Grant
Jun 19
Form 4
1.29K
Dec 28, 2020
1.29K
Grant
Dec 22
Form 4
1,666.91%
5.30M
$17.34
Oct 15, 2020
5.62M
Purchase
Oct 14
Form 3
Oct 08, 2020
Showing 9 results

TCR2 THERAPEUTICS INC.

Investor
Updated Feb 21, 2019
Form 4
-83.85%
-4.19M
Feb 21, 2019
807.26K
Options
Feb 19
Form 3
Feb 13, 2019
Showing 2 results

HOOKIPA Pharma Inc.

Investor
Updated Apr 24, 2019
Form 4
1,064.30%
913.49K
Apr 24, 2019
999.32K
Options
Apr 23
Form 3
Apr 17, 2019
Showing 2 results

Cabaletta Bio, Inc.

Investor
Updated Oct 29, 2019
Form 4
-33.33%
-348.19K
Oct 29, 2019
696.38K
Options
Oct 29
Form 3
Oct 24, 2019
Showing 2 results

Annexon, Inc.

Investor
Updated Jul 30, 2020
Form 4
-88.65%
-12.47M
Jul 30, 2020
1.60M
Options
Jul 28
Form 3
Jul 23, 2020
Showing 2 results

MedAvail Holdings, Inc.

Investor
Updated Jun 21, 2023
Form 4
77.83M
Jun 21, 2023
77.83M
Grant
Jun 16
Form 4
77.83M
$0.32
$25.00M
Mar 13, 2023
77.83M
Grant
Mar 09
Form 4
51.42%
25.58M
$1.06
$18.12M
Jul 06, 2022
75.32M
Grant
Jul 01
Form 4
191.21%
21.18M
$1.06
$15.00M
Apr 06, 2022
32.25M
Grant
Apr 04
Form 3
Nov 27, 2020
11.72M
Showing 5 results

Aprea Therapeutics, Inc.

Investor
Updated Feb 16, 2021
Form 4
-22.04%
-500.00K
$5.58
-$2.79M
Feb 16, 2021
1.77M
Sale
Dec 28
Form 4
94.79%
1.10M
$15.00
Oct 08, 2019
2.27M
Purchase
Oct 07
Form 3
Oct 02, 2019
Showing 3 results

ARRAY BIOPHARMA INC

Investor
Updated Sep 30, 2016
Form 4
-13.02%
-2.49M
$6.36
-$15.85M
Sep 30, 2016
16.66M
Sale
Sep 28
Form 4
$3.51
$3.43K
Sep 16, 2016
19.15M
Purchase
Sep 14 - Sep 15
Form 4
1.59%
300.00K
$3.19
$957.00K
Jan 22, 2016
19.15M
Purchase
Jan 20
Form 4
0.40%
75.00K
$3.60
$270.00K
Jan 14, 2016
18.85M
Purchase
Jan 12
Form 4
5.18%
925.00K
$3.67
$3.39M
Jan 11, 2016
18.78M
Purchase
Jan 07 - Jan 11
Form 4/A
3.48%
600.14K
$4.58
$2.75M
Jan 11, 2016
17.85M
Purchase
Sep 29 - Oct 01
Form 4
4.54%
782.59K
$4.58
$3.58M
Oct 01, 2015
18.03M
Purchase
Sep 29 - Oct 01
Form 4
0.29%
49.90K
$5.48
$273.45K
Aug 28, 2015
17.25M
Purchase
Aug 26
Form 4
4.81%
790.00K
$5.38
$4.25M
Aug 25, 2015
17.20M
Purchase
Aug 21 - Aug 25
Form 4
3.35%
532.50K
$5.88
$3.13M
Aug 13, 2015
16.41M
Purchase
Aug 11 - Aug 12
Form 4
7.07%
1.05M
$5.80
$6.08M
Aug 10, 2015
15.88M
Purchase
Aug 06 - Aug 10
Form 3
Aug 10, 2015
14.83M
Showing 12 results

Zymeworks Inc.

Investor
Updated Oct 18, 2022
Form 4/A
0.50%
30.48K
$5.03
$153.44K
Oct 18, 2022
6.08M
Purchase
Oct 13
Form 4
0.50%
30.48K
$5.03
$153.44K
Oct 17, 2022
6.08M
Grant
Oct 13
Form 3
Oct 17, 2022
6.05M
Form 3
Oct 17, 2022
6.05M
Showing 4 results

ADC Therapeutics SA

Investor
Updated Jul 03, 2024
Form 4
2.87%
800.00K
$2.81
$2.25M
Jul 03, 2024
28.66M
Purchase
Jul 01
Form 4
14.27M
$4.81
$68.67M
May 10, 2024
14.27M
Purchase
May 08
Form 4
137.94%
1.74M
$2.10
-$167.18K
Feb 09, 2024
3.00M
Purchase
Jan 03 - Feb 07
Form 3
Feb 09, 2024
27.86M
Showing 4 results